Merit Medical Systems

Company Snapshot

Founded: 1987
Entity Type: Public
Employees: 7,400
Region: U.S.
Revenue: $1,356.5 Millions
Revenue Year: 2024
Headquarter: Utah, U.S.
Key Geographics: U.S.
Corporate Address: 1600 West Merit Parkway, South Jordan, Utah 84095 U.S. Tel. +1-801-253-1600 www.merit.com

Company Overview

Founded in 1987, Merit Medical Systems Inc. is a leading manufacturer, designer, developer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures. The company aims to build a global customer-focused healthcare environment by understanding the patients’ needs and delivering a distinct array of products that are beneficial to the lives of people throughout the world. Merit Medical primary focuses on inflation devices used in angioplasty and stent placement diagnostic and therapeutic catheters for various procedures in cardiology and radiology, and embolotherapeutic products for the treatment of uterine fibroids, hypervascularized tumors, and arteriovenous malformations. DFINE, a subsidiary of Merit Medical Systems, deals with the STAR tumor ablation system, thereby complementing and enhancing the overall oncology business of the company. The product divisions of this company include, cardiac intervention products, peripheral intervention products and endoscopy products. The company has a presence in North America and Europe.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Merit Medical Systems In Reports

Global Markets for Catheters

According to BCC Research detailed report on catheters market This report analyzes the market trends of the global catheter market with data from 2024, estimates from 2025, projections of compound annual growth rates...

Ablation Devices: Technologies and Global Markets

BCC Research Market Report says global market for ablation devices is estimated to increase from $6.5 bln in 2022 to reach $11.3 bln by 2027, at a (CAGR) of 11.8%.

Biopsy Devices: Technologies and Global Markets

BCC Research Market Report says biopsy devices market should reach $3.1 billion by 2027 from $2.2 billion in 2022 at a compound annual growth rate of 6.8%.

Company's Business Segments

  • Cardiovascular : This segment includes Peripheral Intervention, Cardiac Intervention, Custom Procedural Solutions, OEM.
  • Endoscopy : This segment includes Endoscopy Devices.

Applications/End User Industries

  • Cardiac
  • Endoscopy
  • Original Equipment Manufacturer
  • Manufacturers
  • Clinical Areas
  • Radiology
  • Diagnostic
  • Cardiology
  • Orthopedic
  • Oncology
  • Healthcare
  • Medical Devices
AI Sentiment